Oncomine Comprehensive Assay Test
Cost: AED 13,740.0
Test Name: Oncomine Comprehensive Assay Test
Components: Paraffin embedded tissue blocks
Sample Condition: Tumor tissue
Report Delivery: 2-3 weeks
Method: Next-Generation Sequencing (NGS)
Test Type: Genetics
Doctor: General Physician
Test Department: DNA Labs UAE
Pre Test Information
The Oncomine Comprehensive Assay Test requires a doctor’s prescription. However, it is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.
Test Details
The Oncomine Comprehensive Assay Test is a next-generation sequencing (NGS) panel designed to detect genetic alterations in cancer. It covers over 500 genes and can identify mutations, copy number variations, and gene fusions. The assay is compatible with various sample types, including formalin-fixed paraffin-embedded (FFPE) tissue, fresh frozen tissue, and liquid biopsy samples. Please note that the Oncomine Comprehensive Assay Test is currently intended for clinical research purposes and is not approved for diagnostic use.
Running on the Ion Torrent sequencing platform, the assay utilizes semiconductor sequencing technology known for its speed and accuracy. This platform is ideal for NGS-based assays.
The Oncomine Comprehensive Assay Test provides researchers with a comprehensive view of the genomic landscape of a tumor, enabling a more personalized approach to cancer treatment. As research progresses on the genetic basis of cancer, assays like this one will play an increasingly vital role in the development of personalized cancer treatments.
| Test Name | Oncomine Comprehensive Assay Test |
|---|---|
| Components | Paraffin embedded tissue blocks |
| Price | 13740.0 AED |
| Sample Condition | Tumor tissue |
| Report Delivery | 2-3 weeks |
| Method | NGS |
| Test type | Genetics |
| Doctor | General Physician |
| Test Department: | |
| Pre Test Information | Oncomine Comprehensive Assay can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
| Test Details | The Oncomine Comprehensive Assay is a next-generation sequencing (NGS) panel that is designed to detect genetic alterations in cancer. The panel covers over 500 genes and can identify mutations, copy number variations, and gene fusions. The assay is designed to work with a variety of sample types, including formalin-fixed paraffin-embedded (FFPE) tissue, fresh frozen tissue, and liquid biopsy samples. The Oncomine Comprehensive Assay is intended for use in clinical research and is not currently approved for diagnostic use. It is designed to provide researchers with a comprehensive view of the genomic landscape of a tumor, allowing for a more personalized approach to cancer treatment. The assay is run on the Ion Torrent sequencing platform, which uses semiconductor sequencing technology to detect genetic alterations. The platform is known for its speed and accuracy, making it an ideal choice for NGS-based assays. Overall, the Oncomine Comprehensive Assay is a powerful tool for cancer research, providing researchers with a comprehensive view of the genomic alterations in a tumor. As more research is done on the genetic basis of cancer, assays like this one will become increasingly important for developing personalized cancer treatments. |
